Dr. Dima is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 2018 - 2021
University of AthensClass of 2017
Certifications & Licensure
OH State Medical License 2021 - 2025
WA State Medical License 2024 - 2025
MA State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 2 citationsSafety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma.Surbhi Sidana, Krina K Patel, Lauren C Peres, Radhika Bansal, Mehmet H Kocoglu
Blood. 2025-01-02 - Global disparities in drug-related adverse events of patients with multiple myeloma: a pharmacovigilance study.Majid Jaberi-Douraki, Xuan Xu, Danai Dima, Sikander Ailawadhi, Faiz Anwer
Blood Cancer Journal. 2024-12-20 - Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy.Maximilian Merz, Danai Dima, Hamza Hashmi, Nausheen Ahmed, Friedrich Stölzel
Blood Cancer Journal. 2024-12-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
